QuickView for KU55933 (compound)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens

1. Inhibiting the Activity of ABCG2 by KU55933 in Colorectal Cancer.
2. ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose up…
3. Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using …
4. The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell da…
5. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.

There were no clinical trials for KU55933